Tumor-associated fibroblasts (TAFs) mediated monocytes’ migration into tumor sites by secreting CXCL12 and induced their transformation into CD14+HLA-DR-/low MDSCs by IL-6 mediated STAT3 activation. Here, CXCL12 is linked to neoplasm.